$WGS

$62.74 +$1.48 (2.42%) Close

$WGS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 29.8M shares outstanding

Who owns WGS?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 105.2%

Keith A. Meister 18.0% · Corvex Management LP 16.0%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

222

-18 vs last qtr

Net shares bought

+190.9K

by institutions in Q2 2026

New / sold out

55 / 73

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Corvex Management LP +1.6M
Casdin Capital, LLC +700.0K

Biggest sellers in Q2 2026

Westfield Capital Management Co LP SOLD OUT −1.4M
Invesco Ltd. −520.2K

Who is planning to sell?

Notices of proposed sale, last 12 months

$20.1M

6 notices from 4 people

Shares covered

188.2K

0.63% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Katherine Stueland Director $10.3M
Ruch Joshua Director $6.09M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+179.8%

+40.91% a year

Each share's claim on the business

−64.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $83.6M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years53% 1–3 years22% Under 1 year25%

Quarterly turnover

28.5%

of institutional shares changed hands

Top 10 managers, median time held

4.8 years

Super Investors

Investment managers reporting WGS on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
CM Corvex Management LP 13D · 16.1%	4.8M	16.04%	+1.6M (+48.2%)	2021	10.0%
Shares held by quarter Peak holding4.8M (Q2'26) Change over 8 quarters+2.3M Share of the company16.040% Disclosed stake13D · 16.1% Corvex Management LP's full portfolio →
CC Casdin Capital, LLC 13D · 11.8%	3.7M	12.43%	+700.0K (+23.3%)	2021	12.7%
Shares held by quarter Peak holding3.7M (Q2'26) Change over 8 quarters+200.0K Share of the company12.430% Disclosed stake13D · 11.8% Casdin Capital, LLC's full portfolio →

Corvex Management LP

13D · 16.1%

4.8M

% of company

16.04%

Change vs last qtr

+1.6M (+48.2%)

Held since

2021

Casdin Capital, LLC

13D · 11.8%

3.7M

% of company

12.43%

Change vs last qtr

+700.0K (+23.3%)

Held since

2021

28 more super investors behind a free account

See every manager holding GeneDx Holdings Corp., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting WGS on Form N-PORT; together they hold 32.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AI ARK Innovation ETF ARK ETF Trust	$57.1M	876.6K	2.94%	1.03%	July 31, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$41.7M	607.8K	2.04%	0.00%	June 30, 2026

ARK Innovation ETF

ARK ETF Trust

Position value

$57.1M

% of company

2.94%

% of the fund

1.03%

As of

July 31, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$41.7M

% of company

2.04%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding GeneDx Holdings Corp. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
KA Keith A. Meister 5%+ holder 13D · 17.9%	5.4M	17.96%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company17.960% Disclosed stake13D · 17.9% View the 13D/G filing →
EC Eli Casdin 5%+ holder 13D · 13.7%	4.1M	13.75%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company13.750% Disclosed stake13D · 13.7% View the 13D/G filing →

Keith A. Meister

5%+ holder13D · 17.9%

5.4M

% of company

17.96%

Change vs last qtr

—

Held since

—

Eli Casdin

5%+ holder13D · 13.7%

4.1M

% of company

13.75%

Change vs last qtr

—

Held since

—

6 more holders behind a free account

See every insider and 5%+ holder of GeneDx Holdings Corp..

Comments